Dipna Pharmachem Ltd.

3.89-0.1 (-1.52%)

23 Oct, 12:00 AM

Income Statement

Abridged

Understanding Income Statement

Dipna Pharmachem Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	30.54	31.00	72.76	99.93	164.34	124.92	129.08
Cost of Operating Revenue	28.95	29.59	68.56	95.51	157.94	113.75	107.54
Gross Profit	1.58	1.41	4.19	4.42	6.40	11.17	21.54
Gross Margin	5.2	4.6	5.8	4.4	3.9	8.9	16.7
Total Operating Expenses	30.10	30.61	70.52	97.60	160.93	121.49	124.10
Operating Profit	0.44	0.39	2.24	2.33	3.41	3.42	4.98
Operating Margin	1.4	1.3	3.1	2.3	2.1	2.7	3.9
Financing Income/(Expense) - Net	-0.39	-0.35	-0.67	-0.96	-2.00	-2.02	-1.46
Profit before Taxes	0.06	0.06	1.57	1.38	1.42	1.42	3.54
Income Taxes	0.00	0.03	0.41	0.47	0.33	0.45	0.91
Profit after Tax	0.06	0.02	1.17	0.91	1.09	0.97	2.63
PAT Margin	0.2	0.1	1.6	0.9	0.7	0.8	2.0
EPS - Basic - ex Extraordinary Items	0.04	0.02	0.80	0.63	0.90	0.41	1.00
EPS - Diluted - ex Extraordinary Items	0.04	0.02	0.80	0.63	0.90	0.41	1.00
EBIT	0.44	0.39	2.24	2.33	3.41	3.42	4.98
EBITDA	0.45	0.40	2.24	2.34	3.43	3.43	5.00
EBITDA Margin	1.5	1.3	3.1	2.3	2.1	2.7	3.9

Balance Sheet

Abridged

Understanding Balance Sheet

Dipna Pharmachem Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	PR	PR	PR	AR	AR	AR	PRESS
Total Current Assets	18.40	24.75	36.19	77.52	132.87	132.33	154.09
Property Plant & Equipment - Net	0.04	0.04	0.04	0.04	0.04	0.05	0.07
Total Non-Current Assets	0.04	0.04	0.04	0.04	0.04	0.05	51.54
Total Assets	18.44	24.79	36.23	77.56	132.91	132.38	205.63
Total Current Liabilities	14.53	20.54	31.16	39.02	82.84	85.00	133.23
Long Term Debt	3.36	3.68	3.33	14.18	12.55	8.89	10.10
Total Non-Current Liabilities	3.36	3.68	3.33	14.18	12.55	8.89	10.10
Total Liabilities	17.89	24.22	34.49	53.20	95.39	93.89	143.33
Total Shareholders' Equity	0.55	0.57	1.74	24.36	37.52	38.49	62.30
Total Equity	0.55	0.57	1.74	24.36	37.52	38.49	62.30
Total Liabilities & Equity	18.44	24.79	36.23	77.56	132.91	132.38	205.63

Cash Flow

Abridged

Understanding Cash Flow Statement

Dipna Pharmachem Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	C 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2020 Mar 31	2021 Mar 31	C 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	0.07	0.04	1.17	0.92	1.10	0.98	2.64
Working Capital - Increase/(Decrease)	-3.57	-2.82	1.03	-22.86	-8.51	-12.20	-22.43
Net CF from Operating Activities	-3.50	-2.78	2.20	-21.93	-7.41	-11.21	-19.79
Capital Expenditures - Net	0.00	0.01	0.01	0.01	0.01	0.02	0.04
Net CF from Investing Activities	0.00	-0.01	-0.01	-0.01	-0.01	-0.02	-0.04
Stock - Issuance/(Retirement) - Net	-	-	-	21.71	12.08	-	2.91
Debt - LT & ST - Issuance/(Retirement) - Total	3.56	2.86	-2.24	5.72	3.54	-2.22	-0.92
Net Cash Flow from Financing Activities	3.56	2.86	-2.24	27.43	15.61	-2.22	20.26
Free Cash Flow to Equity	0.06	0.08	-0.04	-16.22	-3.89	-13.45	-20.74
Free Operating CF net dividend	-3.50	-2.78	2.19	-21.94	-7.43	-11.23	-19.83
Free Operating CF	-3.50	-2.78	2.19	-21.94	-7.43	-11.23	-19.83

Business Segment Analysis

Dipna Pharmachem Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Dipna Pharmachem Ltd.

Regional Segment Analysis

Dipna Pharmachem Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Dipna Pharmachem Ltd.

Historical Segment Analysis

Track how Dipna Pharmachem Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Dipna Pharmachem Ltd.

Frequently Asked Questions

What is the revenue of Dipna Pharmachem Ltd.?

The latest trailing twelve month revenue of Dipna Pharmachem Ltd. is ₹ 129.08 Cr, reflecting a 1-year growth of 3.34% and a 3-year CAGR of 8.91%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Dipna Pharmachem Ltd.?

The latest trailing twelve month net profit (PAT) of Dipna Pharmachem Ltd. is ₹ 2.63 Cr, with a 3-year earnings CAGR of 16.90%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Dipna Pharmachem Ltd.?

The trailing twelve month EBITDA of Dipna Pharmachem Ltd. is approximately ₹ 4.98 Cr (based on an operating margin of 3.86%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Dipna Pharmachem Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Dipna Pharmachem Ltd. is 1.00. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Dipna Pharmachem Ltd.?

The debt-to-equity ratio of Dipna Pharmachem Ltd. stands at 0.21. The interest coverage ratio is 3.41x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Dipna Pharmachem Ltd.?

The estimated book value per share of Dipna Pharmachem Ltd. is 23.70 (derived from a P/B ratio of 0.16 and market price of ₹ 3.89), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Dipna Pharmachem Ltd.?

The trailing twelve month operating cash flow of Dipna Pharmachem Ltd. is ₹ -19.79 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Dipna Pharmachem Ltd. report consolidated or standalone financials?

Dipna Pharmachem Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.